scispace - formally typeset
T

Tamaki Kato

Researcher at Kyushu Institute of Technology

Publications -  71
Citations -  1196

Tamaki Kato is an academic researcher from Kyushu Institute of Technology. The author has contributed to research in topics: Tetrapeptide & Histone deacetylase. The author has an hindex of 17, co-authored 68 publications receiving 1135 citations.

Papers
More filters
Journal Article

Cyclic Hydroxamic-acid-containing Peptide 31, a Potent Synthetic Histone Deacetylase Inhibitor with Antitumor Activity

TL;DR: CHAP31 was selected as one of the strongest CHAPs, and its biological activity was characterized further, and suggested to be promising as a novel therapeutic agent for cancer treatment.
Journal ArticleDOI

Quasi-solid dye sensitised solar cells filled with ionic liquid--increase in efficiencies by specific interaction between conductive polymers and gelators

TL;DR: Photo-energy conversions for quasi-solid dye sensitised solar cells increased when gel electrolytes were combined with conductive polymers as counter electrodes and the conversion surpassed that for DSSCs equipped with conventional Pt counter electrodes.
Journal ArticleDOI

Quasi-solid dye sensitized solar cells solidified with chemically cross-linked gelators: Control of TiO2/gel electrolytes and counter Pt/gel electrolytes interfaces

TL;DR: In this article, a small amount of water was added in order to decrease initial viscosities for ionic liquid type gel precursors to impregnate into nano-pores in TiO2 layers.
Journal ArticleDOI

Cyclic tetrapeptides bearing a sulfhydryl group potently inhibit histone deacetylases.

TL;DR: New inhibitors of histone deacetylase (HDAC) containing a sulfhydryl group were designed on the basis of the corresponding hydroxamic acid (CHAP31) and FK228 and exhibited potent HDAC inhibitory activity in vivo with potential as anticancer prodrugs.
Journal ArticleDOI

Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones.

TL;DR: Cyclic tetrapeptides containing trifluoromethyl and pentafluoroethyl ketone as zinc binding functional group were synthesized as potent HDAC inhibitors and showed to be promising anticancer agents.